Delcath Systems Inc (DCTH)

[Rapture2020]

Yes alas it must. We all don’t have a wormhole to jump through, Sam, but if we did, we never would have touted a share price of $370 like you’ve previously done.

And sir, we’re balls in with Phase 3, with a far, far likelier chance for success then at any other time.

While you say I tout and pump, I only excitedly acknowledge the Delcath truism of February 2018: fundamentals are stronger than they have been in a year; they own their IP; they have negotiated directly with FDA; their interim safety analysis report was aces; and the shoe has yet to drop on all those who bought the placement. Oh, and earnings in the next 4 weeks.

The price of admission is just $.03. SMH.


You’ve been here longer, I’ll give you that. But you’ve been saddled with a history that, well, many of us haven’t.

I don’t see irrational exuberance, just excited for this year. This is the time.